Anticoagulants Market surpassed US$ 31.2 billion in 2021, owing to increasing prevalence of cardiovascular diseases | insightSLICE
The global Anticoagulants market size was estimated to be US$ 31.2 billion in 2021 and is expected grow at a CAGR of 6% between 2023 to 2032.
The report observes the global market shares, trends, analysis, and projections for Anticoagulants Market. With the year 2020 acting as the historical period and 2021 as the base year, the projection timeline spans through the years 2023 to 2032.
Access the sample report: https://www.insightslice.com/request-sample/367
The study will analyze the major companies involved in the global Anticoagulants products, as well as estimate their market growth. The competitive environment is also taken into consideration in the analysis.
Aside from noteworthy changes, the research will also examine company strategies, R&D initiatives, staff sizes, and executive officers for all top market players.
The key players of the Global Anticoagulants Market are:
Pfizer, Inc., Portola Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Aspen Holdings, Bayer AG, GlaxoSmithKline plc., Daiichi Sankyo Company, Limited, Janssen Pharmaceuticals, Inc. (A Johnson & Johnson company), and Sanofi S.A. are significant market participants in the anticoagulants market.
Driving factors for the growth of Global Anticoagulants Market
The primary drivers of the global anticoagulant market’s expansion include the high prevalence and rising number of patients with cardiovascular illnesses, rising hip and knee replacement surgery rates, atrial fibrillation increase, and rising cases of deep vein thrombosis (DVT).
Anticoagulants work by interacting with the blood’s clotting components to stop blood clots from forming. The anticoagulant interacts with either the thrombin and fibrinogen or vitamin K present in the blood to stop the synthesis of fibrin, which then stops the clot formation process.
Read more about the report inclusions: https://www.insightslice.com/anticoagulants-market
The most significant risk factor for thrombosis, strokes and other cardiac conditions is atrial fibrillation. The need for anticoagulants for the treatment and prevention of heart problems caused by atrial fibrillation is increasing significantly as more individuals experience atrial fibrillation or arrhythmic heartbeats.
Likewise, the most significant factor driving the demand for anticoagulants in the global market is the surge in the number of people who suffer from pulmonary embolism (PE) and deep venous thrombosis (DVT). In the upcoming years, a major increase in demand for anticoagulants is anticipated.
Report methodology and coverage:
With an emphasis on every functioning business category, the research offers an in-depth analysis of significant players holding the majority share of the global market and would identify the firm segment concentrating on anticoagulants.
Additionally, the market shares of well-known businesses operating in the worldwide anticoagulants market will be calculated.
For example, GlaxoSmithKline plc. recorded revenue of USD 41,736.8 million in 2019, and according to the company’s study of its product segments, the pharmaceuticals business sector generated the majority of the company’s revenue in 2019.
GlaxoSmithKline plc., for instance, conducts business in three different areas: pharmaceuticals, vaccines, and consumer health. The company’s pharmaceuticals business area, which contributed US$21,705.5 million in sales in 2019, provides anticoagulants.
Important competitive data from all anticoagulant businesses, including company strategy, brand portfolio, open opportunities, SWOT analysis, including development and research ambitions, are taken into account in the study.
The actors involved in the market’s distribution chain and value-added networks, as well as their contributions, will be taken into account in the analysis of the global market for anticoagulants. All of the items in the company’s anticoagulants business sector would be the primary priority of the product portfolio segment of this report.
Similarly, the recent developments section would concentrate on the most recent firm activities, including global expansion, mergers and acquisitions, the launch of new products, and strategic partnerships and collaborations in the global anticoagulants industry.
Related reports:
Global Digital PCR Market: https://www.insightslice.com/digital-pcr-market
Global Diabetes Treatment Devices Market: https://www.insightslice.com/diabetes-treatment-devices-market
Global Anticoagulants Market Key Segments:
By Drug Class
- Factor XA Inhibitors (NOAC/DOAC)
- Heparins
- Direct Thrombin Inhibitors
- Vitamin K Antagonists
By Route of Administration
- Oral
- Injectable
By Indication
- Deep Vein Thrombosis
- Pulmonary Embolism
- Atrial Fibrillation & Heart Attack
- Ischemic Stroke
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
Regional performance of Anticoagulants Market
Due to its high incidence of cardiovascular diseases and growing amount of pulmonary embolism patients, North America accounted for the highest share of the global anticoagulants market and is expected to continue to dominate during the projection period (PE).
During the forecast period, it is predicted that the presence of major pharmaceutical companies, rising consumer awareness of lifestyle disorders and cardiovascular health, and rising investment in new product development will support the expansion of the anticoagulant market in North America.
Due to rising investments in the medicines industry’s development, the rise of medical tourism, the prevalence of cardiorespiratory disorders, and growing awareness of cardiovascular health throughout large nations, Asia Pacific is predicted to have the fastest-growing market during the forecast period.
Proceed to purchase: https://www.insightslice.com/buy-now/367
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
